Fluctuation of the prevalence of beak and feather disease virus in captive psittacines in Iran.

Beak and feather disease virus (BFDV) is one of the most life-threatening viral agents infecting parrot species. In this study, we investigated fluctuation in the prevalence of beak and feather disease virus (BFDV) in captive psittacines in Iran. Two series of feather samples from different psittacine species, received between July 2019 and July 2021 (n = 1009) and between July 2021 and July 2022 (n = 2020), were examined for the presence of BFDV using the PCR method, and the host species distribution and temporal prevalence of BFDV within populations were calculated. The results showed a total viral prevalence of 26.86% and 26.88% within sample series 1 and 2, respectively. By examining both sample series, the prevalence of BFDV was found to be  the highest (P < 0.05) in Nymphicus hollandicus and the lowest (P < 0.05) in Psittacus erithacus, Myiopsitta monachus, Pyrrhura molinae, and Aratinga solstitialis. The viral prevalence was significantly higher (P < 0.05) within the series 1 than the series 2 samples only in Nymphicus hollandicus. Within series 2, the viral prevalence was significant (P < 0.05) in samples from Nymphicus hollandicus collected in March. This study indicates significant prevalence of BFDV in captive Nymphicus hollandicus populations and suggests that the fluctuation in the prevalence of BFDV could be due to the combined influence of host-species and temporal factors.

A review on camelid nanobodies with potential application in veterinary medicine.

The single variable domains of camelid heavy-chain only antibodies, known as nanobodies, have taken a long journey since their discovery in 1989 until the first nanobody-based drug's entrance to the market in 2022. On account of their unique properties, nanobodies have been successfully used for diagnosis and therapy against various diseases or conditions. Although research on the application of recombinant antibodies has focused on human medicine, the development of nanobodies has paved the way for incorporating recombinant antibody production in favour of veterinary medicine. Currently, despite many efforts in developing these biomolecules with diversified applications, significant opportunities exist for exploiting these highly versatile and cost-effective antibodies in veterinary medicine. The present study attempts to identify existing gaps and shed light on paths for future research by presenting an updated review on camelid nanobodies with potential applications in veterinary medicine.